We recently compiled a list of the 12 Best Booming Stocks to Invest in Now. In this article, we are going to take a look at ...

PHILADELPHIA, PA — Imvax, Inc, recently closed a $29 million financing round from existing investors. This marks the latest milestone in the company’s fundraising efforts, which have totaled $86 ...

Israel has released a total of 183 Palestinian prisoners in exchange for three Israeli hostages held in Gaza as part of the ...

Equities research analysts at StockNews.com began coverage on shares of DURECT (NASDAQ:DRRX – Get Free Report) in a research note issued on Thursday. The firm set a “sell” rating on the specialty ...

Beyond called off its $40 million investment deal with The Container Store. The parent company of Bed, Bath and Beyond in November cast doubt on the deal, expressing concerns the specialty retailer ...

Shares of GH Research climbed after the company said it would provide data from a trial of its drug for treatment-resistant depression. The stock rose 5.2%, to $11.15, in after-hours trading on Friday ...

GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today announced that it will host a ...

Staunton's Thomas Chisley broke a 24-year-old track and field record. Hanger leads Fort boys. A look at the Region 2B playoff standings for boys and girls.

Topline results were announced from a phase 2/3 trial evaluating linsitinib for the treatment of moderate to severe thyroid eye disease.

Data from the first 16 weeks of the open-label extension phase of the RewinD-LB trial are expected in 1Q 2025 and will include data from participan ...

Metsera and Maze Therapeutics have become the second and third biotechs to complete an initial public offering (IPO) on the ...

Patrick Trucchio, an analyst from H.C. Wainwright, reiterated the Buy rating on Mind Medicine (MNMD – Research Report). The associated price ...